Abstract
This is a protocol for a Cochrane Review (intervention).
This review aims to assess the benefits and harms of GLP‐1 receptor agonists to treat diabetes in people with CKD.
- Record Identifier
- 9926494693101891
- Title
- Glucagon‐like peptide 1 (GLP‐1) receptor agonists for people with chronic kidney disease and diabetes (Protocol)
- Creators
- Patrizia NataleSuetonia C PalmerDavid J TunnicliffeTadashi ToyamaGiovanni FM Strippoli
- Publication Details
- Cochrane database of systematic reviews, Vol.2023(4), CD015849
- Academic Unit
- Medicine (UOC)
- Publisher
- Wiley
- Date published ; e-published
- 17/04/2023
- Comment
- The published version is not available in full-text in OUR Archive. Where available, a link to the published version is provided (check the DOI and/or the Files and links section). The full-text item may be open access on the publisher's website. An earlier version of the work (such as authors' accepted manuscript following peer-review or unreviewed preprint/author's original version) may be available in the Files and links section of this record. Alternatively, readers may have subscription access to the full-text from the publisher.
- Language
- English
- Resource Type ; Subtype
- Journal article; Research Protocol